USA - New York Stock Exchange - NYSE:CI - US1255231003 - Common Stock
The current stock price of CI is 278.95 USD. In the past month the price increased by 6.23%. In the past year, price decreased by -0.01%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.72 | 101.94B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 124.05 | 22.82B | ||
| LH | LABCORP HOLDINGS INC | 15.92 | 20.88B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.87 | 19.40B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.19B | ||
| DVA | DAVITA INC | 12.07 | 7.87B | ||
| HIMS | HIMS & HERS HEALTH INC | 58.69 | 7.21B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 36.79 | 6.77B | ||
| CHE | CHEMED CORP | 20.2 | 6.29B | ||
| RDNT | RADNET INC | 205.79 | 6.03B | ||
| OPCH | OPTION CARE HEALTH INC | 21.34 | 5.05B | ||
| WGS | GENEDX HOLDINGS CORP | 72.01 | 3.91B |
The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 73,500 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
THE CIGNA GROUP
900 Cottage Grove Road
Bloomfield CONNECTICUT 06002 US
CEO: David M. Cordani
Employees: 73500
Phone: 18602266000
The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 73,500 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
The current stock price of CI is 278.95 USD. The price decreased by -1.75% in the last trading session.
THE CIGNA GROUP (CI) has a dividend yield of 2.13%. The yearly dividend amount is currently 5.53.
CI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
CI stock is listed on the New York Stock Exchange exchange.
33 analysts have analysed CI and the average price target is 332.04 USD. This implies a price increase of 19.03% is expected in the next year compared to the current price of 278.95.
The Revenue of THE CIGNA GROUP (CI) is expected to grow by 10.96% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 3 / 10 to CI. When comparing the yearly performance of all stocks, CI is a bad performer in the overall market: 74.04% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to CI. There are concerns on the financial health of CI while its profitability can be described as average.
Over the last trailing twelve months CI reported a non-GAAP Earnings per Share(EPS) of 28.41. The EPS increased by 3.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.29% | ||
| ROA | 3.89% | ||
| ROE | 14.7% | ||
| Debt/Equity | 0.74 |
33 analysts have analysed CI and the average price target is 332.04 USD. This implies a price increase of 19.03% is expected in the next year compared to the current price of 278.95.
For the next year, analysts expect an EPS growth of 11.68% and a revenue growth 10.96% for CI